For instance, miR-210 has been linked to chemotherapy resistance in laryngeal cancer [9], while miR-93 has been connected to poor prognosis through its targeting of cyclin G2 (CCNG2) [10]. This evidence concerns the gene CCNG2 and laryngeal carcinoma.